News

February 21, 2020February 21, 2020

Spanish Modified Story Memory Technique Improves Cognitive Performance in Mexican Patients with MS, Study Says

News

The Spanish version of the modified Story Memory Technique improves learning and life satisfaction of Mexican patients with multiple sclerosis (MS), a new study suggests.  The tool, developed by ... Read more

February 21, 2020February 21, 2020

Flowonix’s Prometra II Pump System Receives FDA Approval for Use with Intrathecal Baclofen

News

  The U.S. Food and Drug Administration (FDA) has granted approval to Flowonix Medical’s Prometra II Programmable Pump System for use with intrathecal baclofen for the treatment of spasticity across numerous ... Read more

February 20, 2020February 20, 2020

#ACTRIMS2020 – Keynote Speaker Peter Calabresi to Discuss Link Between Genetics and MS Severity

News

Specific mutations in genes that provide instructions to make two proteins —  called C3 and C1q — are linked to increased severity of multiple sclerosis (MS), according to new ... Read more

February 20, 2020February 20, 2020

Bone Marrow Transplant Can Replace Overactive Immune Cells, Preventing Inflammation in MS, Study Says

News

A bone marrow transplant can remove the majority of overactive immune T cells from the central nervous system (CNS) in patients with active relapsing-remitting multiple sclerosis (RRMS), allowing the ... Read more

February 19, 2020February 19, 2020

University Spin-Off Pheno Therapeutics to Search for Compounds to Re-Grow Myelin Lost in MS

News

Pheno Therapeutics, a spin-off from the University of Edinburgh, in Scotland, will search for new molecules capable of inducing the body to repair or replace the myelin sheath that is ... Read more

February 19, 2020February 19, 2020

Bike MS Fundraiser Will See Tri Global Energy Back on Saddle for 5th Year

News

Tri Global Energy is again joining with fellow Texans for Bike MS, the nationwide fundraising cycling series of the National Multiple Sclerosis Society (NMSS). Team Wind Force will saddle up May ... Read more

February 18, 2020February 18, 2020

Incontinence in MS Affects Walking Ability, Negatively Impacts Patients’ Quality of Life, Study Finds

News

Urinary incontinence,  associated with poor functioning of the muscles in the pelvic area, was found to have a negative impact on daily activities like walking and overall quality of ... Read more

February 18, 2020February 18, 2020

How Astrocytes Promote Inflammation in Patients’ Brain Detailed in Early Study

News

Using brain tissue from people with multiple sclerosis (MS) and mouse models of MS, scientists identified a key pathway that drives astrocytes to promote inflammation in the brain and spinal cord. ... Read more

February 17, 2020February 17, 2020

Number of People with MS in UK More Than Previously Estimated

News

New data from Public Health England (PHE) and the U.K. MS Society show that the number of people with multiple sclerosis (MS) in the United Kingdom is now more ... Read more

February 17, 2020February 17, 2020

Insomnia and MS Given Intimate Focus in Short Film ‘Awake’ by UK Group

News

Insomnia, and all that repeat sleepless nights mean, burden a vast majority — 85% — of people with multiple sclerosis (MS), a survey of patients who are part of ... Read more

February 14, 2020February 21, 2020

Urinary Diversion Surgery May Be Used as Last Resort for Treating Urological Dysfunction in MS Patients, Study Shows

News

A surgical technique known as non-continent urinary diversion is an effective last-resort solution for treating urological dysfunction in people with multiple sclerosis (MS), a new study shows. Titled “Outcomes ... Read more

February 14, 2020February 21, 2020

Ocrevus Use Rises Among New Starters with RRMS, Loses Ground to Other Therapies in PPMS

News

First-line use of Genentech‘s Ocrevus (ocrelizumab) for patients with multiple sclerosis (MS) has remained stable through 2019 compared to 2018, according to the latest Spherix Global Insights‘ report. However, ... Read more

February 13, 2020February 13, 2020

MS Patients Needing Feeding Tubes May Live Longer if Given Before Age 50, Study Finds

News

Placing a feeding tube before age 50 in multiple sclerosis (MS) patients with dysphagia, or difficulties swallowing, may extent their life by more than two years, a study suggests. These findings ... Read more

February 13, 2020February 13, 2020

Gold Nanocrystals in Phase 2 Testing Show ‘Robust’ Remyelination Potential in Animal Models

News

Clene Nanomedicine‘s remyelination therapy candidate, CNM-Au8, showed a “robust” ability to stimulate the production of new myelin and increase the number of myelin-wrapped nerve fibers in the brain and ... Read more

February 12, 2020February 12, 2020

Gilenya Works to Treat RRMS by Specifically Targeting B-cells and T-helper Cells, Study Finds

News

Treating people with relapsing-remitting multiple sclerosis (RRMS) for one year with the immune-modulating therapy Gilenya (fingolimod) reduced the numbers of antibody-producing B-cells and of T helper cells, a study finds.  ... Read more

February 12, 2020February 12, 2020

Rituximab Appears Safe for Women to Use While Breastfeeding, Small Study Finds

News

Rituximab is barely detected in breast milk of women with relapsing-remitting multiple sclerosis (RRMS) who took the therapy while breastfeeding their child, small study shows. Results suggest that women with ... Read more

February 11, 2020February 18, 2020

Cognitive Decline in MS May Not Be Inevitable or Progressive, 10-year Study Suggests

News

Progressive cognitive decline in patients with multiple sclerosis (MS) may not be as inevitable as previously thought, a study suggests. The study, “A longitudinal study of cognitive function in ... Read more

February 11, 2020February 13, 2020

Inflammasome Pathway Linked to MS and Diseases of Aging Has an ‘Off’ Switch, Early Study Says

News

Immune cells have an inflammation ‘switch’ that involves the NLRP3 inflammasome pathway, and targeting it may prevent or even reverse the chronic inflammation seen in diseases like multiple sclerosis ... Read more

February 10, 2020February 11, 2020

Ethnic Differences in MS Evident in Antibody-secreting Cells in Blood, US Study Suggests

News

People with multiple sclerosis (MS) who self-identify black African or Latin American have a higher number of disease-associated antibody-secreting cells in their blood compared to those who identify as ... Read more

February 10, 2020February 10, 2020

Mavenclad May Be Added to RRMS Treatments on Quebec’s Public Health Plan

News

The agency in charge of health and social services for Quebec, known as the Institut national d’excellence en santé et en services sociaux (INESSS), is recommending that Mavenclad (cladribine) be offered ... Read more

February 7, 2020February 7, 2020

Fewer New Brain Lesions Seen in Patients Treated with BTK Blocker in Phase 2 Trial, Results Show

News

The experimental BTK inhibitor SAR442168 showed an acceptable safety profile and met its primary endpoint — a significant reduction in the number of new lesions visible on a brain ... Read more

February 7, 2020February 7, 2020

‘Seeing’ Protein Density in Blood May Help in Early MS Diagnosis by Subtype, Work Suggests

News

A way of detecting the density of proteins in the blood, called “magnetic levitation” or MagLev, may aid in more quickly diagnosing chronic diseases, including the particular type of multiple ... Read more

February 6, 2020February 6, 2020

Interleukin-17A Plays Key Role in Inflammation in MS, Mouse Study Finds

News

The immune signaling molecule interleukin-17A (IL-17A) promotes the recruiting of inflammatory cells to the central nervous system (brain and spinal cord) in a multiple sclerosis (MS) mouse model, a ... Read more

February 6, 2020February 19, 2020

Dietary Changes May Delay Development and Progression of MS, Study Finds

News

Changing a person’s diet to reduce the amount of methionine (amino acid found in food) could delay the development and progression of inflammatory and autoimmune disorders, including multiple sclerosis (MS). ... Read more

February 5, 2020February 5, 2020

Having Other Health Conditions Does Not Raise Risk of MS-related Hospitalization, Study Finds

News

Having other health conditions, or comorbidities, along with multiple sclerosis (MS) does not increase a person’s risk of being hospitalized due to MS-specific symptoms, although it does raise the ... Read more

February 5, 2020February 5, 2020

QyScore, Imaging Software that Analyzes MRI Markers of Brain Disease, Earns FDA Clearance

News

The U.S. Food and Drug Administration (FDA) has granted 510(k) clearance for QyScore, a cloud-based imaging software for the automated quantification of key magnetic resonance imaging (MRI) markers of central nervous ... Read more

February 4, 2020February 4, 2020

Mesenchymal Stem Cell Transplant Safe and Helps Delay MS Progression, Analysis Shows

News

Transplanting patients’ own mesenchymal stem cells (MSCs) is a safe therapeutic approach and can delay disease progression in people with multiple sclerosis (MS), a meta-analysis review shows. The study also ... Read more

February 4, 2020February 4, 2020

Cerebrospinal Fluid of MS Patients More Diverse and Filled with Pro-Inflammatory Cells, Study Shows

News

People with multiple sclerosis (MS) have a more diverse set of immune cells in their cerebrospinal fluid (CSF), the fluid that bathes the central nervous system, but no such ... Read more

February 3, 2020February 3, 2020

Interaction Between Different Immune Cells May Lead to New MS Therapies, Study Suggests

News

Scientists discovered new interaction between immune cells from the central nervous system (CNS) — consisting of the brain and spinal cord — and immune cells from the blood that ... Read more

February 3, 2020February 3, 2020

MSAA Marks 50th Anniversary with Benefit Evening, New Logo and More

News

The Multiple Sclerosis Association of America (MSAA) is celebrating 50 years of work and dedication to improving the lives of people affected by multiple sclerosis (MS). Some changes are ... Read more

January 31, 2020February 7, 2020

FDA OKs Device to Monitor Blink Reflex, Potential Way of Detecting MS Early

News

EyeStat, a portable device to measure blink reflex, has been cleared for use by the U.S. Food and Drug Administration (FDA). On the heels of promising results for assessing ... Read more

January 31, 2020January 31, 2020

Harvard Scientist Awarded National MS Society’s Barancik Prize for Work in MS

News

Harvard professor and scientist Francisco Quintana, PhD, has been awarded the 2019 Barancik Prize for Innovation in MS Research for his work in understanding what causes multiple sclerosis (MS), ... Read more

January 30, 2020February 7, 2020

Nonprofits RARE Courage, All Wheels Up Partner on Survey Seeking to Improve Air Travel for Wheelchair Users

News

Kevin Schaefer hadn’t been in an airport since he was 4 years old, so he had been looking forward to flying from his home in Cary, North Carolina, to ... Read more

January 30, 2020January 30, 2020

Epstein-Barr Virus and Certain Genes Interact in Ways That Can Promote MS, Study Finds

News

Interaction between various Epstein-Barr virus traits and the composition of certain genes affects the risk of developing multiple sclerosis (MS), a study reports. The study, “The interaction of Multiple ... Read more

January 30, 2020January 30, 2020

Multiple Factors Influence the Prevalence of Lower Urinary Tract Symptoms in MS Patients, Study Indicates

News

Age, gender, disease subtype, degree of disability, and more factors affect lower urinary tract symptoms (LUTS) among patients with multiple sclerosis (MS). Also, the epidemiology of LUTS must be better ... Read more

January 29, 2020January 29, 2020

Mental Health of Women Affected by Caring for Children with MS, Study Suggests

News

Caring for children with multiple sclerosis (MS) can affect the mental health of their mothers over the long term, a study has found. The study, “Increased mental health care ... Read more

January 29, 2020February 4, 2020

New Imaging Agent of Myelin for Earlier MS Diagnosis, Myeliviz, Entering Clinical Testing

News

The U.S. Food and Drug Administration (FDA) has agreed to allow Myeliviz, an imaging agent of myelin — the protective layer that covers nerve fibers and is damaged in multiple sclerosis (MS) — to be ... Read more

January 28, 2020January 28, 2020

New Research Shows How Nerve Impulses Travel, May Offer Insights to Effects of MS Demyelination

News

Nerve impulses travel in a “dual cable” with myelin, playing additional roles to what was previously thought, new research has found. This discovery advances human knowledge of how brain ... Read more

January 28, 2020January 28, 2020

MS Research Australia Grant to Help Doctors Better Diagnose, Treat Depression

News

A psychologist at Swinburne University of Technology in Melbourne has been awarded an incubator grant by MS Research Australia to identify ways to better detect and treat depression in people with multiple sclerosis ... Read more

January 27, 2020February 7, 2020

Living Near Major Roadways Raises Risk of MS and Other Neurologic Ills, Study Says

News

People living close to major roads or highways are at a greater risk of multiple sclerosis (MS), a database study of people in metropolitan Vancouver reports. Parks and other green spaces ... Read more